Affirm Holdings heads into its fiscal Q4 report today with options traders at their most defensive reading of the year, even as short sellers have spent the past month aggressively unwinding positions.
The options signal is the clearest tension in the setup. The put/call ratio has climbed to 1.19, more than two standard deviations above its 20-day average of 1.10 — the highest defensive skew in 52 weeks, with a year-high of 1.23 just above. That elevated put demand stands in sharp contrast to what short sellers have actually been doing. Short interest has fallen 23% over the past month, dropping from roughly 18.7 million shares in mid-July to just under 13.9 million, now at 4.8% of free float. Borrow conditions reinforce the picture: availability runs at 1,491% relative to outstanding shorts — well into loose territory — and cost to borrow, despite a 49% weekly uptick to 0.47%, remains firmly low by any historical measure. Short sellers have been stepping back. Options buyers are still paying for protection.
The analyst community has moved decisively bullish ahead of the print. Goldman Sachs, JPMorgan, Oppenheimer, and Bernstein have all raised targets in recent weeks, with Goldman at $106 and Oppenheimer lifting to $100. Morgan Stanley nudged its target to $80 just yesterday while holding an Equal-Weight rating — the lone sidelines voice in an otherwise upbeat chorus. The consensus mean sits at $91.67, roughly 20% above the current $76.46 close, framing a meaningful expectations gap. Bulls anchor on BNPL market leadership, the Amazon and Shopify partnership anchor, and the potential for a banking charter to meaningfully compress funding costs. Bears point to heavy US concentration, consumer credit sensitivity to macro conditions, and execution risk around the charter application itself — a binary regulatory outcome that the valuation does not obviously price in either direction.
JP Morgan Asset Management stands out among institutional holders, adding nearly 9.9 million shares in the most recent reported period to reach a 4.3% stake — the largest single-quarter addition among the top holders. Capital Research remains the largest external shareholder at 14.7%, also adding modestly. Insider activity is routine rather than notable: small scheduled sells from the President and COO, all low-significance, with no net directional signal worth reading into.
The print therefore tests whether the revenue and GMV trajectory can validate a consensus that has already re-rated sharply higher — and whether the banking charter story remains intact enough to sustain the gap between where the stock trades and where analysts believe it belongs.
See the live data behind this article on ORTEX.
Open AFRM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
